As of February 2025, China already had 60-70 late-stage (Phase 2 or later) pipeline assets, directly competing with semaglutide, tirzepatide and other candidates in diabetes and weight loss
In 2024, Wegovy also received FDA approval to reduce the risk of cardiovascular death, non-fatal myocardial infarction, and non-fatal stroke in adults with established cardiovascular disease and either obesity or overweight
The age of these patients ranged from 6 to 65 years old
GLP-1 medications typically cost between $800 and $1,300 per month without insurance coverage, depending on the specific drug and dose
Eriomin, a patented lemon extract made mainly of eriocitrin, which is one of the plant pigments that give lemons their color
a stable 13 C-labeled fatty acid breath test) and reliance on self-reported symptoms rather than validated symptom indices for gastrointestinal disorders are also limitations